Mupirocin

This classification denotes a topical anti-infective agent with the molecular formula C26H44O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D0GX863OA5, chemically known as 8-carboxyoctyl (e)-4-(2s,3r,4r,5s)-5-((2s,3s,4s,5s)-2,3-epoxy-5-hydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2h-pyran-2-yl)-3-methylcrotonat but more generally known as mupirocin, which bears US NIH Compound Identifier 446596. European Medicines Agency schedules Mupirocin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09093MIG. The term MUPIROCIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 39, No. 5, 1985, List 25). The World Health Organization schedules mupirocin in its Anatomical Therapeutic Chemical (ATC) Classification. MUPIROCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O1C(C1C(C(O)C)C)CC1C(O)C(O)C(OC1)C/C(=C/C(=O)OCCCCCCCCC(=O)O)C.